Blue Biofuels Q2 2026: Cash Drops to $22K, Going Concern Warning Reiterated, Massive Option Modifications
BIOF sits 65% above its 52-week low of $0.066.
Summary
Blue Biofuels' Q2 2026 filing reveals a cash balance of just $22,040, a going concern warning, and a massive option modification that will heavily dilute shareholders if the company survives.
Key Events · Earnings and Guidance · BIOF
-
Cash Near Zero
Cash and equivalents fell to $22,040 as of June 30, 2026, down from $65,200 at year-end 2025. The company burned $687,359 in operating activities during the first half of 2026.
-
Going Concern Warning Reiterated
Management again states substantial doubt about the company's ability to continue as a going concern, citing recurring losses, a $3.3 million working capital deficit, and no revenue.
-
Massive Option Modification
On June 24, 2026, the board converted 40.6 million performance-based options to time-based vesting, resulting in a $3.3 million non-cash compensation charge. An additional anti-dilution commitment will require issuing more options to maintain management's ownership percentages through the next $50 million raised.
-
Dilutive Financing Continues
The company raised $347,000 through private placements of shares and warrants, and issued $210,000 in convertible notes during the quarter. Since June 30, it raised another $92,500 in notes and warrant exercises.
Analysis · BIOF · Industrial Applications And Services
Blue Biofuels is running on fumes. Cash fell to just $22,040 — barely enough to cover two weeks of operating expenses. The company again warns it may not survive without new financing, and its accumulated deficit now exceeds $61 million. Meanwhile, the board modified 40.6 million performance-based options to time-based vesting, triggering a $3.3 million non-cash charge, and committed to issue more options to maintain management's ownership percentages through the next $50 million in fundraising. These actions dilute existing shareholders and signal that management is securing its own interests while the company teeters on the edge. The $347,000 raised in private placements and $210,000 in new convertible notes are stopgaps, not solutions.
At the time of this filing, BIOF was trading at $0.11 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $34.9M. The 52-week trading range was $0.07 to $0.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.